We present a re-engineered frequency-domain tissue oximeter operating in the near-infrared spectral region. This instrument is based on the multi-distance measurement protocol, which we have implemented in our original design by multiplexing multiple light sources. The new instrument uses intensity modulated (1 10 MHz) laser diodes emitting at 750and 840 nm. The laser diodes are coupled to glass optical fibers (600 tm core diameter). The average light intensity delivered to the tissue is about 3 mW. The multiplexing electronics are based on solid state switches that allow for acquisition times per point as short as tens ofmilliseconds. Our tests on phantoms and in vivo with the new oximeter have shown significant improvement in terms of stability, reliability, and reproducibility with respect to the original prototype. Furthermore, by using optical fibers we achieve a high versatility in the design of the measuring probe, permitting custom design for various tissue contours and different measurements. To verify the improved performance of the new oximeter, we have performed an in vivo test consisting ofmonitoring the hemoglobin saturation (Y)and concentration (THC) on the calfof 18 healthy volunteers during walking and running routines.
INTRODUCTION
In 1994 we developed a frequency-domain spectrometer for the optical study ofbiological tissues.' This instrument, which is based on a multi-distance measurement protocol,2 quantitatively measures the absorption (ta) fld reduced scattering (k') coefficients of the investigated tissue at two near-infrared wavelengths. The simultaneous measurement of ji fld Lç' constitutes the main novelty with respect to previous tissue oximeters. No assumptions are required about the photon path length or the scattering properties of the tissue. The separation of the absorption and scattering contributions to the attenuation of light in turbid media has been accomplished also by other methods such as steady state multi-distance, 3'4 frequency-domain multi-frequency,5 and time-domain measurements. 6 The frequency-domain multi-distance approach holds appeal in tissue oximetry for several reasons : 1) In contrast to the steady state approach, the measurement of absolute values can be done at relatively large sourcedetector separations (a few centimeters). The photon penetration depth is thus adequate to investigate tissues below the skin layer. 2) Since a and p' are derived from the relative readings collected at different source-detector separations, any effect that influences those readings to the same extent will cancel. For example, drifts in the signals sent to the light sources and/or to the optical detector by the power supplies have no influence on the measurement ofthe optical coefficients.
3) The instrumentation is relatively compact and cost-effective. It does not require the wide frequency range necessary for multi-frequency studies, or the short laser pulses and sophisticated detection methods used in the time-domain. 4) Real time monitoring is feasible since the acquisition times can be shorter than a second.
The absolute values of hemoglobin concentration and saturation can be derived from the absorption coefficients at the two wavelengths. The instrument works under two main assumptions: (i) Hemoglobin is the dominant absorber in tissues in the SPIE Vol. 2979 • 0277-786X197/$1O.OO spectral region considered (700-850 nm); (ii) The investigated tissue is macroscopically homogeneous. The first assumption is often well satisfied. The software of the instrument corrects for the small contribution of the absorption of water.7 The second assumption is more critical, especially for an instrument based on a multi-distance approach. Based on preliminary measurements, we believe that this assumption is fulfilled when large muscle volumes are investigated.
The first generation prototype, used eight light emitting diodes (LED's) (four with peak wavelength at 715 nm, four with peak wavelength at 825 nm) which were mounted directly on the measuring probe in contact with the skin. The distances between the light sources and the detection optical fiber ranged from 1.5 to 3.5 cm, yielding a photon penetration depth into the tissue in the approximate range 0.5-2 cm. The LED's were sinusoidally modulated at a frequency of 110 MHz, and turned on and off in sequence by means of mechanical relays. This first generation prototype was tested in several laboratories, and it was used for measurements on phantoms1'8 and in vivo.913 Together, these measurements provided encouraging results and yielded valuable information about technical and practical limitations of the instrument. These limitations have been careftully considered by us, leading to the development of a second generation instrument. In this paper, we describe the limitations ofthe first prototype, and the solutions implemented in the new prototype to overcome them. As a test of the new prototype, we present in vivo data collected on the calf of 18 healthy subjects during walking and running exercises on a treadmill.
THE DEVELOPMENT OF THE NEW FREQUENCY-DOMAIN TISSUE OXIMETER

Strengths and weaknesses of the initial design
The results obtained with the initial prototype confirmed the effectiveness of the frequency-domain multi-distance approach in the optical study oftissues. The measured changes in hemoglobin saturation and concentration were in agreement with the readings of steady state oximeters, but in addition to that, the frequency-domain technique afforded quantitative readings of absolute values ofthese parameters.'3 The quantitative values correlated well with invasive measurements based on drawing arterial and venous blood." The instrumentation was extremely compact, thus allowing for measurements at the bed side. On the basis of these initial results, we have kept the basic design. In re-engineering the instrument to improve performance, we have focused our attention on the practical and technical limitations that were identified. The issues we have focused on include:
(1) Stability ofthe optical signal; (2) Adequate signal to noise; (3) Reproducibility ofthe calibration procedure; (4) Ease of application ofthe measuring probe.
Many of these problems were related to our initial choice of light emitting diodes (LED's) as light sources, and to the design of their driving electronics. The average optical power emitted by the LED's (-3OO j.tW) was at the limit of what is needed to obtain measurable signals at source-detector separations of 3 cm or more. In tissues showing higher-thanaverage absorption, we had problems associated with the low signal level. In these conditions, we could not couple the LED's to optical fibers, since this would have introduced additional losses and even less optical power delivered by the fiber to the tissue. Having the LED's directly in contact with the skin, in turn caused more difficulties:
(a) The measuring probe was bulky and rigid and there was not much latitude for design improvement; (b) It was necessary to deliver the radio frequency (RF) signal (1 10 MHz) to the measuring probe via an RF cable. Even though the cable was shielded, radio frequency pick up and changes in the transmitted signal due to subject movement caused significant disturbances; (c) The investigated tissue was not electrically isolated from the LED's driving electronics (especially when LED's with a metallic case were used); (d) The shape ofthe LED's accounted for a lack ofreproducibility in the calibration procedure.
The calibration procedure, which is described in Ref. 1 , consists of positioning the probe on a medium with known optical properties. The software calculates the corrective factors for the dc, ac, and phase of each light source to account for the variability in the outputs of the different light sources (were their outputs exactly equal, the calibration procedure would not be needed). The calibration procedure was not highly reproducible when we used LED's. The difference in the corrective factors calculated in repeated positionings of the probe on the calibration block, accounted for an error of about 10-15% in the absolute readings of the optical coefficients but, of course, not in the relative changes of the readings.
The new design
As a result of the effectiveness of th& measurement protocol, the multi-distance approach based on multiplexing multiple light sources has been maintained in the new prototype. The main changes involve the introduction of fiber-coupled laser diodes, and newly designed driving electronics.
In the new prototype, we use eight laser diodes, four emitting at 750nm (Sharp LTO3OMD), and four emitting at 840 urn (Sharp LTO11MS). The laser diodes are coupled to glass optical fibers (600 jtm core diameter) by means of SMA connectors. The outputs ofthe laser diodes corresponding to the shortest source-detector separations are attenuated by means ofneutral density filters. In this fashion, we collect a comparable signal from all ofthe laser diodes. The higher optical power emitted by the laser diodes, together with a better fiber coupling efficiency, results in an optical power of about 3 mW delivered to the tissue (about one order of magnitude larger than what we had with LED's). Delivering the light signal by fiber optics also allows us to keep all the electronics and RF signals inside a well shielded box, which results in a higher signal stability. Furthermore, there is a higher degree of flexibility in the design of the measuring probe, since it now involves only fiber optics. The calibration procedure turns out to be more reproducible as a result ofthe uniform geometry of the eight fibers in the probe. The systematic error in the absolute readings of the optical coefficients introduced by the calibration procedure is now reduced to about 5% from 10-15% for the LED system.
Among the changes in the light source driving electronics, we note the use of TTL switches, instead of mechanical relays, to turn the various sources on and off. This modification allows us to achieve faster switching times, so that the ON time is now limited by the protection circuit which turns on the laser diodes (-3 ms). Taking advantage of this opportunity, we have increased the cross-correlation frequency to 5 KHz (in the past we used cross-correlation frequencies in the range 400 -1250 Hz). Fast acquisition times on the order of 100 ms are now possible. We have also changed the way in which the various light sources are turned on during the acquisition time. In the past, we simply had each ofthe eight LED's on for 1/8 of the acquisition time. Now, we always keep each laser diode on for 100 periods of the cross-correlation signal (i.e. 20 ms for the 5 KHz cross-correlation frequency). In this way, for the case of eight laser diodes, we have a minimum acquisition time of 160 ms (one cycle). Longer acquisition times are obtained by combining more cycles. were directly mounted on the measuring probe, which also contained the driving electronics. The dc intensity (Fig. 2(a) ) is more stable in the new prototype. The point-to-point fluctuation is 0.1%, versus 0.5%for the old prototype. More importantly, there is only a constant drift (which usually disappears after the instrument warms up), and there are no jumps or changes in the trend. The phase (Fig. 2(b) ) shows a similar effect. The point-to-point fluctuation is now comparable in the two instruments (-0.2 degrees) but the signal is more stable in the new prototype. The calculated plots of a(Fi g. 2(c)) and ' (Fig. 2(d) ) show the improvement achieved with the new design. The hemoglobin saturation typically reached a plateau during exercise (see Figs. 3(a) and (b) ). By contrast, the total hemoglobin concentration did not always reach a plateau, and in those cases we have taken the value at the end of the exercise as the "exercise" value, as indicated in Figs. 3(c) and (d) .
TEST ON PHANTOMS
To test the new frequency-domain tissue oximeter in vivo, we performed a set of measurements on the calf of 1 8 healthy subject (12 males, average age 34; 6 females, average age 33; all Caucasian). The measuring probe was kept in place by elastic bands and the instrumental readings were monitored during walking (speed: -2.l miles per hour), and running (speed: -4.2 miles per hour) exercises on a flat treadmill. 12 subjects performed both walking and running exercises, 2 subjects performed only the walking, and 4 subjects performed only the running exercise. Acquisition time per data point was set to 1 .28 s. The routine consisted of acquiring a baseline for 3 minutes, then the walking (running) exercise was started and lasted 6 (3) minutes. Finally, the recovery was followed for about 10 minutes with the subject always standing up. Typical traces of hemoglobin saturation (1) and total hemoglobin concentration (THC) are shown in Fig. 3 . The "baseline" and "exercise" parameters are indicated in the figures for both the walking and running routines, while the differences Y and M'HC ("exercise" -"baseline") are shown in the figures for the running routine (Figs. 3(b) and 3(d) ). Table I shows the average and standard deviations of the baseline, walking, and running values of Y and THC, over the 18 subjects (14 for the walking routine, 16 for the running routine). Figure 4 shows the changes in Y and THC for both the walking and running routines. The physiological information collected in this in vivo test indicates that the hemoglobin saturation decreases from the baseline value during exercise. The decrease during the walking routine (-2±2% for males; -4±3% for females) is considerably less than during the running routine (-15±7% for males; -9±4% for females). By contrast, the total hemoglobin concentration shows both positive and negative variations during the exercise. The absolute value of the variation is 5±6 .tM for males, 7±3 tM for females during walking, and 7±6 jtM for males, 5±7 M for females during running. The changes of Y and THC during exercise with respect to the baseline values are reported in the histograms of Fig. 4 . We are in the progress of analyzing this physiological information in more detail to better understand its relevance and it implications. Changes in the hemoglobin saturation (left panels) and concentration (right panels) during the walking (upper panels) and running (lower panels) routines. These histograms report the number of subjects showing a change in the measured parameter within the range reported below each one of the bars. The total numberof subjects for the walking exercise was 14, while for the running exercise it was 16. 
DISCUSSION
In conducting this in vivo test we experienced the significant practical improvements achieved with the new prototype. The optical coupling between the fiber optics and the skin was consistently the same for all of the eight source fibers. This condition is extremely important in multi-distance measurements, and results in more reliable and reproducible measurements. The movements (jarring during the running exercise) ofthe subject did not cause any spikes or artifacts in the measured traces. As a result, we never had reason to discard a data set, which was sometimes done with the previous prototype because ofnon uniform optical couplings and/or movement artifacts. The short on-period of each laser diode (20 ms) allowed us to complete an acquisition cycle (80 ms per wavelength) in a time much shorter than the heart beat, respiratory periods, and the stride period. To quantify the reduction in the measurement noise resulting from this new procedure, we have also acquired data with a 1250 Hz cross-correlation frequency (80 ms per laser diode, 320 ms per wavelength). Figure 5shows the lower noise associated with shorter time per cycle. The data is acquired on the calf during a running exercise. Physiological rhythms on a time scale of the order of one second are not a concern at the higher cross-correlation 10 frequency.
CONCLUSION
We have presented a second generation frequency-domain tissue oximeter which operates in the near-infrared. In its design, we have kept the basic principle of acquiring data at multiple source-detector separations by multiplexing multiple light sources. This approach was implemented in a first generation prototype which has given promising results both on phantoms and in vivo. The technical improvements achieved with the new design result in a more practical, reliable, reproducible, and versatile unit, which is more appropriate for clinical trials. In conducting the in vivo measurements presented in this paper, we have verified the improvement in the design and engineering of the instrument. We have started clinical trials where the technical and practical effectiveness of the new prototype has been confirmed. We conclude by observing that the data collected by this tissue oximeter also include continuous wave (CW) data (i.e. the dc intensity), and single distance data. This means that we are able to compare the effectiveness of cw and single-distance methods with respect to our frequency-domain multi-distance approach. We are currently working on this topic. 
